David Glover

Corporate Officer/Principal presso University of Cambridge

Consumer Services

Health Technology

Commercial Services

Profilo

David Glover is the founder of Cyclacel Pharmaceuticals, Inc., which was founded in 1996.
He held the title of Chief Scientist at the company.
Currently, Dr. Glover is a Professor at the University of Cambridge, starting in 2013.
He is also a Member of the European Molecular Biology Organization.
In the past, he worked as a Director at Cancer Research UK, a Professor & Head-Biochemistry at Imperial College London, and a Professor-Molecular Genetics at the University Of Dundee.

Posizioni attive di David Glover

Società	Posizione	Inizio
University of Cambridge	Corporate Officer/Principal	-
European Molecular Biology Organization	Corporate Officer/Principal	-

Tutte le posizioni attive di David Glover

Precedenti posizioni note di David Glover

Società	Posizione	Fine
Cancer Research UK Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.	Direttore/Membro del Consiglio	21/06/2011
University Of Dundee	Corporate Officer/Principal	-
Imperial College London	Corporate Officer/Principal	-
CYCLACEL PHARMACEUTICALS, INC.	Fondatore	-

Vedi nel dettaglio l'esperienza di David Glover

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Glover

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CYCLACEL PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
European Molecular Biology Organization
Cancer Research UK Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.	Commercial Services